A very interesting listen on Joe Rogan's most recent podcast (you don't need to be a fan of his to listen to the quality guests he sometimes gets).
Dr Malhotra talks about Statins, Covid Vaccines, AND the influence of big Pharma on approvals.
With something like 65% of FDA's funding coming direct from Pharma companies, and the profit numbers which are staggering, maybe you get a little insight into the headwinds we have been facing. The great thing about this podcast and the momentum around this type of evidentiary medicine analysis coming out is that "things that work, vs things that simply profit" are being discussed.
Dr Malhotra does chastise the journalism community too about their complicit behaviour in this duping of the public (remind anyone of their favorite Tommy?)
Bring on the truth.....and approvals with it.
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-6384
-
- There are more pages in this discussion • 4,113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.020(2.21%) |
Mkt cap ! $1.047B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 90.5¢ | $2.976M | 3.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 85592 | 92.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 79533 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 255703 | 0.915 |
20 | 234392 | 0.910 |
18 | 307551 | 0.905 |
23 | 338720 | 0.900 |
7 | 1577517 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 37551 | 17 |
0.925 | 77151 | 15 |
0.930 | 177075 | 20 |
0.935 | 215728 | 18 |
0.940 | 120544 | 8 |
Last trade - 13.55pm 07/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
MSB (ASX) Chart |